Celanese raises its notes offering to $1.4B, aiming to bolster liquidity and reshape near-term debt maturities.
Celanese Corporation ( CE ) Q3 2025 Earnings Call November 7, 2025 9:00 AM EST Company Participants William Cunningham - Vice President of Investor Relations Scott Richardson - President, CEO & Director Chuck Kyrish - Senior VP & CFO Conference Call Participants David Begleiter - Deutsche Bank AG, Research Division Vincent Andrews - Morgan Stanley, Research Division Jeffrey Zekauskas - JPMorgan Chase & Co, Research Division Michael Sison - Wells Fargo Securities, LLC, Research Division Ghansham Panjabi - Robert W. Baird & Co. Incorporated, Research Division Patrick Cunningham - Citigroup Inc., Research Division Kevin McCarthy - Vertical Research Partners, LLC Salvator Tiano - BofA Securities, Research Division Aleksey Yefremov - KeyBanc Capital Markets Inc., Research Division Frank Mitsch - Fermium Research, LLC Hassan Ahmed - Alembic Global Advisors Joshua Spector - UBS Investment Bank, Research Division Arun Viswanathan - RBC Capital Markets, Research Division John Ezekiel Roberts - Mizuho Securities USA LLC, Research Division Presentation Operator Greetings.
CE posts sharp earnings fall but tops estimates, with cost cuts and strong cash flow guiding its 2025 outlook.
While the top- and bottom-line numbers for Celanese (CE) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Celanese (CE) came out with quarterly earnings of $1.34 per share, beating the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $2.44 per share a year ago.
Celanese (CE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Celanese Corp (NYSE:CE) stock is up 5.4% to trade at $44.65 at last glance, after the chemicals company was upgraded by Citigroup to "buy" from "neutral," to go with a price-target hike to $53 from $47.
Celanese shares tumbled once again, following the issuance of weak guidance for the rest of the year. While the company's near-term outlook remains highly uncertain, don't overlook the company's strong free cash flow generation. I believe Celanese's debtload is manageable and that shareholders will be richly rewarded once the cycle turns.
GCTS, NE and CE have been added to the Zacks Rank #5 (Strong Sell) List on August 15, 2025.
Celanese Corporation (NYSE:CE ) Q2 2025 Earnings Conference Call August 12, 2025 9:00 AM ET Company Participants e - Corporate Participant r - Corporate Participant c - Corporate Participant e - Corporate Participant Chuck B. Kyrish - Senior VP & CFO Scott A.
Celanese tops Q2 earnings and sales estimates despite lower prices, as cost cuts and cash flow focus help offset demand softness.
The chemicals manufacturer beat the Street's expectations.